相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter Inhibitor, as Add-On to Meiformin in Subjects With Type 2 Diabetes
Julio Rosenstock et al.
DIABETES CARE (2012)
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
R. Grempler et al.
DIABETES OBESITY & METABOLISM (2012)
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin
D. Devineni et al.
DIABETES OBESITY & METABOLISM (2012)
Comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e53, 2011)
V Basevi et al.
DIABETES CARE (2011)
Role of Chronic and Acute Hyperglycemia in the Development of Diabetes Complications
M. Loredana Marcovecchio et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus
Sherwyn L. Schwartz et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
Muhammad A. Abdul-Ghani et al.
ENDOCRINE REVIEWS (2011)
Management of diabetes across the course of disease: minimizing obesity-associated complications
Caroline M. Apovian
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2011)
Standards of Medical Care in Diabetes-2011 AMERICAN DIABETES ASSOCIATION
DIABETES CARE (2011)
Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus Four-Year Results of the Look AHEAD Trial
Rena R. Wing et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Emerging treatment options for type 2 diabetes
Milan K. Piya et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications
J. E. Gerich
DIABETIC MEDICINE (2010)
Dapagliflozin: more than just another oral glucose-lowering agent?
Niki Katsiki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Therapeutic targets to reduce cardiovascular disease in type 2 diabetes (Reprinted from Nature Reviews Drug Discovery, vol 8, pg 361-367, 2009)
Cyrus DeSouza et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Defining and Achieving Treatment Success in Patients With Type 2 Diabetes Mellitus
Mark W. Stolar
MAYO CLINIC PROCEEDINGS (2010)
Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006
Bernard M. Y. Cheung et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects
W. T. CEFALU et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
James F. List et al.
DIABETES CARE (2009)
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers Applicability of a novel insulin-independent treatment
John P. H. Wilding et al.
DIABETES CARE (2009)
Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications
George L. Bakris et al.
KIDNEY INTERNATIONAL (2009)
OPINION Therapeutic targets to reduce cardiovascular disease in type 2 diabetes
Cyrus DeSouza et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999-2004
Kwok Leung Ong et al.
ANNALS OF EPIDEMIOLOGY (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
